nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Distention—Prednisone—ankylosing spondylitis	0.0429	0.043	CcSEcCtD
Methyldopa—Pericarditis—Methotrexate—ankylosing spondylitis	0.0195	0.0196	CcSEcCtD
Methyldopa—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.0145	0.0146	CcSEcCtD
Methyldopa—Vasculitis—Prednisolone—ankylosing spondylitis	0.0142	0.0143	CcSEcCtD
Methyldopa—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.0132	0.0132	CcSEcCtD
Methyldopa—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.0132	0.0132	CcSEcCtD
Methyldopa—Vasculitis—Triamcinolone—ankylosing spondylitis	0.0131	0.0131	CcSEcCtD
Methyldopa—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.0131	0.0131	CcSEcCtD
Methyldopa—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.0125	0.0125	CcSEcCtD
Methyldopa—Liver disorder—Methotrexate—ankylosing spondylitis	0.0124	0.0124	CcSEcCtD
Methyldopa—Endocrine disorder—Prednisone—ankylosing spondylitis	0.0122	0.0122	CcSEcCtD
Methyldopa—Vasculitis—Dexamethasone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Methyldopa—Vasculitis—Betamethasone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Methyldopa—Amenorrhoea—Prednisone—ankylosing spondylitis	0.0115	0.0115	CcSEcCtD
Methyldopa—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.0111	0.0112	CcSEcCtD
Methyldopa—Vasculitis—Prednisone—ankylosing spondylitis	0.0104	0.0104	CcSEcCtD
Methyldopa—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.0102	0.0103	CcSEcCtD
Methyldopa—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Methyldopa—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.00929	0.00931	CcSEcCtD
Methyldopa—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.00929	0.00931	CcSEcCtD
Methyldopa—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00905	0.00907	CcSEcCtD
Methyldopa—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00878	0.0088	CcSEcCtD
Methyldopa—Vasculitis—Methotrexate—ankylosing spondylitis	0.00865	0.00867	CcSEcCtD
Methyldopa—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00855	0.00857	CcSEcCtD
Methyldopa—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00837	0.00839	CcSEcCtD
Methyldopa—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00823	0.00825	CcSEcCtD
Methyldopa—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00823	0.00825	CcSEcCtD
Methyldopa—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00809	0.00811	CcSEcCtD
Methyldopa—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00808	0.0081	CcSEcCtD
Methyldopa—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00806	0.00808	CcSEcCtD
Methyldopa—Weight increased—Prednisolone—ankylosing spondylitis	0.00794	0.00796	CcSEcCtD
Methyldopa—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00787	0.00788	CcSEcCtD
Methyldopa—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00785	0.00787	CcSEcCtD
Methyldopa—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00756	0.00757	CcSEcCtD
Methyldopa—Weight increased—Triamcinolone—ankylosing spondylitis	0.0073	0.00732	CcSEcCtD
Methyldopa—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00729	0.0073	CcSEcCtD
Methyldopa—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00716	0.00718	CcSEcCtD
Methyldopa—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00714	0.00715	CcSEcCtD
Methyldopa—Infestation—Methylprednisolone—ankylosing spondylitis	0.00714	0.00715	CcSEcCtD
Methyldopa—Bradycardia—Prednisolone—ankylosing spondylitis	0.00711	0.00713	CcSEcCtD
Methyldopa—Weight increased—Dexamethasone—ankylosing spondylitis	0.00662	0.00664	CcSEcCtD
Methyldopa—Weight increased—Betamethasone—ankylosing spondylitis	0.00662	0.00664	CcSEcCtD
Methyldopa—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00654	0.00655	CcSEcCtD
Methyldopa—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00652	0.00654	CcSEcCtD
Methyldopa—Abdominal distension—Prednisone—ankylosing spondylitis	0.00638	0.0064	CcSEcCtD
Methyldopa—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.0063	0.00631	CcSEcCtD
Methyldopa—Pancreatitis—Prednisone—ankylosing spondylitis	0.00622	0.00623	CcSEcCtD
Methyldopa—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00595	0.00596	CcSEcCtD
Methyldopa—Bradycardia—Betamethasone—ankylosing spondylitis	0.00593	0.00595	CcSEcCtD
Methyldopa—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00593	0.00595	CcSEcCtD
Methyldopa—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00584	0.00585	CcSEcCtD
Methyldopa—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00581	0.00583	CcSEcCtD
Methyldopa—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00577	0.00579	CcSEcCtD
Methyldopa—Weight increased—Prednisone—ankylosing spondylitis	0.00577	0.00578	CcSEcCtD
Methyldopa—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00566	0.00567	CcSEcCtD
Methyldopa—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00561	0.00563	CcSEcCtD
Methyldopa—Breast disorder—Methotrexate—ankylosing spondylitis	0.00554	0.00555	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00552	0.00553	CcSEcCtD
Methyldopa—Angiopathy—Betamethasone—ankylosing spondylitis	0.00529	0.0053	CcSEcCtD
Methyldopa—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00529	0.0053	CcSEcCtD
Methyldopa—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00525	0.00526	CcSEcCtD
Methyldopa—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00519	0.00521	CcSEcCtD
Methyldopa—Bradycardia—Prednisone—ankylosing spondylitis	0.00517	0.00518	CcSEcCtD
Methyldopa—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00503	0.00504	CcSEcCtD
Methyldopa—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00499	0.005	CcSEcCtD
Methyldopa—Oedema—Prednisolone—ankylosing spondylitis	0.00496	0.00497	CcSEcCtD
Methyldopa—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00488	0.00489	CcSEcCtD
Methyldopa—Myalgia—Triamcinolone—ankylosing spondylitis	0.00476	0.00477	CcSEcCtD
Methyldopa—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00475	0.00476	CcSEcCtD
Methyldopa—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00475	0.00476	CcSEcCtD
Methyldopa—Infestation—Methotrexate—ankylosing spondylitis	0.00472	0.00474	CcSEcCtD
Methyldopa—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00472	0.00474	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00472	0.00473	CcSEcCtD
Methyldopa—Angiopathy—Prednisone—ankylosing spondylitis	0.0046	0.00461	CcSEcCtD
Methyldopa—Oedema—Triamcinolone—ankylosing spondylitis	0.00456	0.00457	CcSEcCtD
Methyldopa—Infection—Triamcinolone—ankylosing spondylitis	0.00453	0.00454	CcSEcCtD
Methyldopa—Infection—Methylprednisolone—ankylosing spondylitis	0.00452	0.00453	CcSEcCtD
Methyldopa—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00447	0.00448	CcSEcCtD
Methyldopa—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00446	0.00447	CcSEcCtD
Methyldopa—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00445	0.00447	CcSEcCtD
Methyldopa—Mental disorder—Prednisone—ankylosing spondylitis	0.00445	0.00446	CcSEcCtD
Methyldopa—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00442	0.00443	CcSEcCtD
Methyldopa—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00441	0.00442	CcSEcCtD
Methyldopa—Myalgia—Betamethasone—ankylosing spondylitis	0.00432	0.00433	CcSEcCtD
Methyldopa—Myalgia—Dexamethasone—ankylosing spondylitis	0.00432	0.00433	CcSEcCtD
Methyldopa—Hepatitis—Methotrexate—ankylosing spondylitis	0.00424	0.00425	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00416	0.00417	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00415	0.00416	CcSEcCtD
Methyldopa—Oedema—Dexamethasone—ankylosing spondylitis	0.00414	0.00415	CcSEcCtD
Methyldopa—Oedema—Betamethasone—ankylosing spondylitis	0.00414	0.00415	CcSEcCtD
Methyldopa—Infection—Betamethasone—ankylosing spondylitis	0.00411	0.00412	CcSEcCtD
Methyldopa—Infection—Dexamethasone—ankylosing spondylitis	0.00411	0.00412	CcSEcCtD
Methyldopa—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0041	0.00411	CcSEcCtD
Methyldopa—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00409	0.0041	CcSEcCtD
Methyldopa—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00406	0.00407	CcSEcCtD
Methyldopa—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00406	0.00407	CcSEcCtD
Methyldopa—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00405	0.00406	CcSEcCtD
Methyldopa—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00405	0.00406	CcSEcCtD
Methyldopa—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00394	0.00395	CcSEcCtD
Methyldopa—Angiopathy—Methotrexate—ankylosing spondylitis	0.00385	0.00386	CcSEcCtD
Methyldopa—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00382	0.00383	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00377	0.00378	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00377	0.00378	CcSEcCtD
Methyldopa—Arthralgia—Prednisone—ankylosing spondylitis	0.00376	0.00377	CcSEcCtD
Methyldopa—Myalgia—Prednisone—ankylosing spondylitis	0.00376	0.00377	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00373	0.00374	CcSEcCtD
Methyldopa—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00372	0.00373	CcSEcCtD
Methyldopa—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00372	0.00373	CcSEcCtD
Methyldopa—Mental disorder—Methotrexate—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Methyldopa—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00361	0.00362	CcSEcCtD
Methyldopa—Oedema—Prednisone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Methyldopa—Infection—Prednisone—ankylosing spondylitis	0.00358	0.00359	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00357	0.00358	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00357	0.00358	CcSEcCtD
Methyldopa—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Methyldopa—Skin disorder—Prednisone—ankylosing spondylitis	0.0035	0.00351	CcSEcCtD
Methyldopa—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00336	0.00337	CcSEcCtD
Methyldopa—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00335	0.00336	CcSEcCtD
Methyldopa—Leukopenia—Methotrexate—ankylosing spondylitis	0.0033	0.00331	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00328	0.00329	CcSEcCtD
Methyldopa—Dizziness—Prednisolone—ankylosing spondylitis	0.00328	0.00329	CcSEcCtD
Methyldopa—Asthenia—Triamcinolone—ankylosing spondylitis	0.00327	0.00328	CcSEcCtD
Methyldopa—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00327	0.00328	CcSEcCtD
Methyldopa—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00327	0.00328	CcSEcCtD
Methyldopa—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Methyldopa—Paraesthesia—Prednisone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Methyldopa—Myalgia—Methotrexate—ankylosing spondylitis	0.00314	0.00315	CcSEcCtD
Methyldopa—Arthralgia—Methotrexate—ankylosing spondylitis	0.00314	0.00315	CcSEcCtD
Methyldopa—Rash—Prednisolone—ankylosing spondylitis	0.00313	0.00314	CcSEcCtD
Methyldopa—Dermatitis—Prednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00312	0.00313	CcSEcCtD
Methyldopa—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00311	0.00312	CcSEcCtD
Methyldopa—Headache—Prednisolone—ankylosing spondylitis	0.00311	0.00312	CcSEcCtD
Methyldopa—Constipation—Prednisone—ankylosing spondylitis	0.00308	0.00309	CcSEcCtD
Methyldopa—Dizziness—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Methyldopa—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00301	0.00302	CcSEcCtD
Methyldopa—Infection—Methotrexate—ankylosing spondylitis	0.00299	0.003	CcSEcCtD
Methyldopa—Asthenia—Betamethasone—ankylosing spondylitis	0.00297	0.00298	CcSEcCtD
Methyldopa—Asthenia—Dexamethasone—ankylosing spondylitis	0.00297	0.00298	CcSEcCtD
Methyldopa—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00295	0.00296	CcSEcCtD
Methyldopa—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00295	0.00296	CcSEcCtD
Methyldopa—Nausea—Prednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Methyldopa—Skin disorder—Methotrexate—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Methyldopa—Vomiting—Triamcinolone—ankylosing spondylitis	0.0029	0.00291	CcSEcCtD
Methyldopa—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00289	0.0029	CcSEcCtD
Methyldopa—Rash—Triamcinolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Methyldopa—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00287	0.00288	CcSEcCtD
Methyldopa—Rash—Methylprednisolone—ankylosing spondylitis	0.00287	0.00288	CcSEcCtD
Methyldopa—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Methyldopa—Headache—Triamcinolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Methyldopa—Headache—Methylprednisolone—ankylosing spondylitis	0.00285	0.00286	CcSEcCtD
Methyldopa—Body temperature increased—Prednisone—ankylosing spondylitis	0.00285	0.00286	CcSEcCtD
Methyldopa—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00283	0.00284	CcSEcCtD
Methyldopa—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00283	0.00284	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00274	0.00275	CcSEcCtD
Methyldopa—Dizziness—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Methyldopa—Dizziness—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Methyldopa—Nausea—Triamcinolone—ankylosing spondylitis	0.00271	0.00272	CcSEcCtD
Methyldopa—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Methyldopa—Nausea—Methylprednisolone—ankylosing spondylitis	0.0027	0.00271	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Methyldopa—Vomiting—Dexamethasone—ankylosing spondylitis	0.00263	0.00264	CcSEcCtD
Methyldopa—Vomiting—Betamethasone—ankylosing spondylitis	0.00263	0.00264	CcSEcCtD
Methyldopa—Rash—Dexamethasone—ankylosing spondylitis	0.00261	0.00262	CcSEcCtD
Methyldopa—Rash—Betamethasone—ankylosing spondylitis	0.00261	0.00262	CcSEcCtD
Methyldopa—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Methyldopa—Dermatitis—Betamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0026	0.00261	CcSEcCtD
Methyldopa—Headache—Betamethasone—ankylosing spondylitis	0.00259	0.0026	CcSEcCtD
Methyldopa—Headache—Dexamethasone—ankylosing spondylitis	0.00259	0.0026	CcSEcCtD
Methyldopa—Asthenia—Prednisone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Methyldopa—Diarrhoea—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Methyldopa—Nausea—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Methyldopa—Nausea—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Methyldopa—Dizziness—Prednisone—ankylosing spondylitis	0.00238	0.00239	CcSEcCtD
Methyldopa—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00238	0.00239	CcSEcCtD
Methyldopa—Epinephrine—TNF—ankylosing spondylitis	0.00237	1	CrCbGaD
Methyldopa—Vomiting—Prednisone—ankylosing spondylitis	0.00229	0.0023	CcSEcCtD
Methyldopa—Rash—Prednisone—ankylosing spondylitis	0.00227	0.00228	CcSEcCtD
Methyldopa—Dermatitis—Prednisone—ankylosing spondylitis	0.00227	0.00228	CcSEcCtD
Methyldopa—Headache—Prednisone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Methyldopa—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Methyldopa—Asthenia—Methotrexate—ankylosing spondylitis	0.00216	0.00217	CcSEcCtD
Methyldopa—Nausea—Prednisone—ankylosing spondylitis	0.00214	0.00215	CcSEcCtD
Methyldopa—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00206	0.00207	CcSEcCtD
Methyldopa—Dizziness—Methotrexate—ankylosing spondylitis	0.00199	0.002	CcSEcCtD
Methyldopa—Vomiting—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Methyldopa—Rash—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Methyldopa—Dermatitis—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Methyldopa—Headache—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Methyldopa—Nausea—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
